October 3 | 2018 Add. info to newsletter ”2cureX GmbH receives contribution for the development of IndiTreat® tests in immuno-oncology” Read more
October 3 | 2018 2cureX tyska dotterbolag erhåller bidrag för utveckling av IndiTreat®-test inom immunonkologi Read more
August 22 | 2018 2cureX strengthen its patent portfolio with the granting of a new European patent Read more
July 20 | 2018 2cureX fortsätter att uppdatera sin frekvent använda Frågor & Svar-sida på www.2curex.com Read more
July 20 | 2018 2cureX continues to update its frequently asked Question page on www.2curex.com Read more
June 21 | 2018 2cureX presents positive clinical data from its IndiTreat® CRC trial at ESMO in Barcelona Read more
June 21 | 2018 2cureX presenterar positiva kliniska data från den kliniska studien med IndiTreat vid ESMO i Barcelona Read more